PAVmed price to book ratio PAVM

Market value divided by the book value of the company's net assets, since 2016.

Today, Oct 23, 2026: 0.5×
10-year median: 4.6×
Against its 10-year history: 19th; percentile: 0 is its lowest day, 100 its highest
10-year range: 0.2× to 199×
Peer median: 1.3×

PAVmed's price to book ratio is 0.5× as of Oct 23, 2026.

That is below its ten-year median of 4.6×, lower than on 81% of days in the last ten years.

Over that time it ranged from 0.2× in Aug 2025 to 199× in Apr 2021.

The median for 3 medical instruments and supplies stocks of a similar size is 1.3×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	0.5×	0.2×	1.9×
2025	0.3×	0.2×	0.3×
2024	n/m a value too high to mean anything
2023	4.7×	4.5×	6.1×
2022	5.0×	1.5×	8.4×
2021	6.2×	6.2×	199×
2020	n/m a value too high to mean anything
2019	8.0×	7.1×	8.0×
2018	6.9×	4.4×	112×
2017	74.5×	59.4×	81.5×
2016	80.3×	50.8×	131×

Against its peers

Companies in Medical - Instruments & Supplies nearest PAVmed's size, closest first, today.

Company	Price to book ratio
PAVMPAVmed	0.5×
NEPHNephros	3.2×
APTAlpha Pro Tech	0.9×
KEQUKewaunee Scientific	1.3×
Peer median	1.3×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on PAVmed

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.